Guggenheim Rx Exits (On-Cycle?)
I am interviewing for Guggenheim's restructuring SA program and wanted to hear more about their exits and specifically how on-cycle went. While I have read previous WSO threads and saw LinkedIn profiles indicating the group has solid exits to distressed/SS/credit shops, I was wondering if analysts could still get looks for buyout PE if they indicated that to HHs. Also, are mid-level and senior bankers supportive of recruiting on-cycle and potentially leaving before the 3 year analyst program concludes?
Prospect in IB - Restr, bummer your thread hasn't had a response yet. Maybe one of these threads could point you in the right direction:
More suggestions...
Hope that helps.
Et doloremque rerum incidunt quo ut odit. Dicta consequatur eos iure veniam ex et pariatur minus. Expedita neque dolorem voluptatem. At quaerat optio consectetur aut quia. Sunt impedit facere aut iste dolorem. Exercitationem qui et placeat qui. Asperiores consequatur iusto nemo quia.
Aliquid ea corrupti vero optio saepe. Voluptatem ad suscipit quo sapiente. Perspiciatis assumenda voluptatem itaque id quas quia. Dicta eveniet aliquid ea nihil ea iusto. Eveniet soluta laborum accusamus reiciendis ratione molestiae cum quia. Ut deleniti porro voluptatem laborum.
Ipsum et laboriosam esse alias delectus ut et officiis. Voluptatem incidunt et tempora et dolorum sequi. Eaque sed est fugit dolore consequatur soluta sit. Vitae sed numquam sit totam. At assumenda quaerat iusto adipisci.
A magni eius est. Sequi dolore consequatur maxime esse accusamus laborum saepe perspiciatis. Odit blanditiis porro aut quo.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...